Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Gilbert

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopesM A Gavin, M J Gilbert, S R Riddell, et al.
The Journal of General Virology|September 1, 1996
Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4C A Hartley, M J Gilbert, L Brigido, et al.
AIDS (London, England)|April 19, 2000
Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study GroupJ B Angel, K High, F Rhame, et al.
The New England Journal of Medicine|October 19, 1995
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donorE A Walter, P D Greenberg, M J Gilbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virusC Yee, M J Gilbert, S R Riddell, et al.
Occupational Medicine (Oxford, England)|December 1, 1995
A systematic approach to health surveillance in the workplaceJ G Bell, C Bishop, M Gann, et al.
The Journal of Infectious Diseases|September 9, 1999
The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trialG Skowron, D Stein, G Drusano, et al.
Human Gene Therapy|June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of OncologyS R Riddell, P D Greenberg, R W Overell, et al.
British Journal of Pharmacology|November 1, 1990
A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptorsS B Freedman, E A Harley, S Patel, et al.
Nature Medicine|February 1, 1996
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patientsS R Riddell, M Elliott, D A Lewinsohn, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopesM A Gavin, M J Gilbert, S R Riddell, et al.
The Journal of General Virology|September 1, 1996
Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4C A Hartley, M J Gilbert, L Brigido, et al.
AIDS (London, England)|April 19, 2000
Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study GroupJ B Angel, K High, F Rhame, et al.
The New England Journal of Medicine|October 19, 1995
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donorE A Walter, P D Greenberg, M J Gilbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virusC Yee, M J Gilbert, S R Riddell, et al.
Occupational Medicine (Oxford, England)|December 1, 1995
A systematic approach to health surveillance in the workplaceJ G Bell, C Bishop, M Gann, et al.
The Journal of Infectious Diseases|September 9, 1999
The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trialG Skowron, D Stein, G Drusano, et al.
Human Gene Therapy|June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of OncologyS R Riddell, P D Greenberg, R W Overell, et al.
British Journal of Pharmacology|November 1, 1990
A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptorsS B Freedman, E A Harley, S Patel, et al.
Nature Medicine|February 1, 1996
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patientsS R Riddell, M Elliott, D A Lewinsohn, et al.
Pageof 4